The prognostic significance of FOXQ1 oncogene overexpression in human hepatocellular carcinoma

Pathology Research and Practice

Volumn 209, Issue 6, 2013, Pages 353-358

  Wang, Wenwen ^a   He, Song ^a   Ji, Juling ^a   Huang, Jianfei ^a   Zhang, Suqin ^a   Zhang, Yixin ^a  

^a NANTONG UNIVERSITY   (China)

Author keywords

Forkhead box gene; FOXQ1; HCC; Oncogene

Indexed keywords

ALPHA FETOPROTEIN; FORKHEAD TRANSCRIPTION FACTOR; MESSENGER RNA; TRANSCRIPTION FACTOR FOXQ1; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER PATIENT; CANCER PROGNOSIS; CANCER SIZE; CANCER STAGING; CANCER TISSUE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOXQ1 ONCOGENE; GENE EXPRESSION; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; TISSUE MICROARRAY;

ADULT; ALPHA-FETOPROTEINS; CARCINOMA, HEPATOCELLULAR; CHI-SQUARE DISTRIBUTION; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REAL-TIME POLYMERASE CHAIN REACTION; RISK FACTORS; RNA, MESSENGER; TIME FACTORS; TISSUE ARRAY ANALYSIS; TUMOR BURDEN; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 84878397119     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2013.03.005     Document Type: Article

References (35)

1. Parkin D.M., Bray F. Global cancer statistics, 2002. CA Cancer J. Clin. 2005, 55:74-108.
2. Venook A.P., Papandreou C. The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective. Oncologist 2010, 15:5-13.
3. World Health Organization, Mortality Database, WHO Statistical Information System, Cited 1 December 2008. Available from URL:. http://www.who.int/whosis.
4. Bosch F.X., Ribes J. Primary liver cancer: worldwide incidence and trends. Gastroenterology 2004, 127(2004):S5-S16.
5. Ye S.L., Takayama T. Current approaches to the treatment of early hepatocellular carcinoma. Oncologist 2010, 15:34-41.
6. Michielsen P., Ho E. Viral hepatitis B and hepatocellular carcinoma. Acta Gastroenterol. Belg. 2011, 74(4):e8.
7. McGivern D.R., Lemon S.M. Virus-specific mechanisms of carcinogenesis in hepatitis C virus associated liver cancer. Oncogene 2011, 30:1969-1983.
8. Marrero J.A., Kudo M. The challenge of prognosis and staging for hepatocellular carcinoma. Oncologist 2010, 15:23-33.
9. Weigel D., Jackle H.H. The fork head domain: a novel DNA binding motif of eukaryotic transcription factors?. Cell 1990, 63:455-456.
10. Brent M.M., Anand R., Marmorstein R. Structural basis for DNA recognition by FOXO1 and its regulation by posttranslational modification. Structure 2008, 16:1407-1416.
11. Wu Y., Borde M., Heissmeyer V., Feuerer M., Lapan A.D., Stroud J.C., Bates D.L., Guo L., Han A., Ziegler S.F., Mathis D., Benoist C., Chen L., Rao A. FOXP3 controls regulatory T cell function through cooperation with NFAT. Cell 2006, 126:375-387.
12. Clark K.L., Halay E.D., Lai E., Burley S.K. Cocrystal structure of the HNF-3/fork head DNA-recognition motif resembles histone H5. Nature 1993, 364:412-420.
13. Zhang H., Meng F., Liu G., Zhang B., Zhu J., et al. Forkhead transcription factor FOXQ1 promotes epithelial-mesenchymal transition and breast cancer metastasis. Cancer Res. 2011, 71:1292-1301.
14. Bieller A., Pasche B., Frank S., Gläser B., Kunz J., et al. Isolation and characterization of the human forkhead gene FOXQ1. DNA Cell Biol. 2001, 20:555-561.
15. Jonsson H., Peng S.L. Forkhead transcription factors in immunology. Cell. Mol. Life Sci. 2005, 62:397-409.
16. LeBlanc M., Kulle B., et al. Genome-wide study identifies PTPRO and WDR72 and FOXQ1-SUMO1P1 interaction associated with neurocognitive function. J. Psychiatr. Res. 2012, 46:271-278.
17. Feuerborn A., Srivastava P.K., et al. The forkhead factor FOXQ1 influences epithelial differentiation. J. Cell. Physiol. 2011, 226:710-719.
18. Qiao Y., Jiang X., Lee S.T., Karuturi R.K., Hooi S.C., et al. FOXQ1 regulates epithelial-mesenchymal transition in human cancers. Cancer Res. 2011, 71:3076-3086.
19. Ogaki S., Harada S., et al. An expression profile analysis of ES cell-derived definitive endodermal cells and Pdx1-expressing cells. BMC Dev Biol 2011, 11:13.
20. Candelario J., Chen L.Y., et al. A filtering strategy identifies FOXQ1 as a potential effector of lamin A dysfunction. Aging (Milano) 2012, 4:567-577.
21. Sunters A., Fernandez de Mattos S., et al. FoxO3a transcriptional regulation of Bim controls apoptosis in paclitaxel-treated breast cancer cell lines. J. Biol. Chem. 2003, 278:49795-49805.
22. Fosbrink M., Niculescu F., et al. C5b-9-induced endothelial cell proliferation and migration are dependent on Akt inactivation of forkhead transcription factor FOXO1. J. Biol. Chem. 2006, 281:19009-19018.
23. Paik J.H., Kollipara R., et al. FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis. Cell 2007, 128:309-323.
24. Wang Y., Yang S., et al. Overexpression of forkhead box J2 can decrease the migration of breast cancer cells. J. Cell. Biochem. 2012, 113:2729-2737.
25. Abe Y., Ijichi N., et al. Forkhead box transcription factor, forkhead box A1, shows negative association with lymph node status in endometrial cancer, and represses cell proliferation and migration of endometrial cancer cells. Cancer Sci 2012, 103:806-812.
26. Tang S.Y., Jiao Y., et al. Significance of forkhead box m1b (Foxm1b) gene in cell proliferation and carcinogenesis. Ai Zheng 2008, 27:894-896.
27. Wendling D.S., Luck C., et al. Characteristic overexpression of the forkhead box transcription factor Foxf1 in Patched-associated tumors. Int. J. Mol. Med. 2008, 22:787-792.
28. Sizemore S.T., Keri R.A. The forkhead box transcription factor FOXC1 promotes breast cancer invasion by inducing matrix metalloprotease 7 (MMP7) expression. J. Biol. Chem. 2012, 287:24631-24640.
29. Xia L., Huang W., et al. Overexpression of forkhead box C1 promotes tumor metastasis and indicates poor prognosis in hepatocellular carcinoma. Hepatology 2013, 57(2):610-624.
30. Hu C.R., Wang J.H., et al. Both FOXP1 and p65 expression are adverse risk factors in diffuse large B-cell lymphoma: a retrospective study in China. Acta Histochem. 2013, 115(2):137-143.
31. Kaneda H., Arao T., Tanaka K., Tamura D., Aomatsu K., et al. FOXQ1 is overexpressed in colorectal cancer and enhances tumorigenicity and tumor growth. Cancer Res. 2010, 70:2053-2063.
32. Feng J., Zhang X., et al. FOXQ1 overexpression influences poor prognosis in non-small cell lung cancer, associates with the phenomenon of EMT. PLoS ONE 2012, 7(6):e39937.
33. Adhikary S., Eilers M. Transcriptional regulation and transformation by Myc proteins. Nat. Rev. Mol. Cell Biol. 2005, 6:635-645.
34. Xu X., Yamamoto H., Sakon M., Yasui M., Ngan C.Y., Fukunaga H., Morita T., et al. Overexpression of CDC25A phosphatase is associated with hypergrowth activity and poor prognosis of human hepatocellular carcinomas. Clin. Cancer Res. 2003, 9:1764-1772.
35. Huang J., Zhang X., et al. Prognostic significance and potential therapeutic target of VEGFR2 in hepatocellular carcinoma. J. Clin. Pathol. 2011, 64:343-348.